PACB
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Key Financials
Net Income
$-546376000
↓ 76.3%
Operating Income
$-553861000
↓ 16.8%
Gross Profit
$45.8M
↑ 22.8%
Revenue
$78.6M
↓ 15.9%
Total Assets
$784.1M
↓ 37.8%
EPS (Diluted)
$-1.82
↓ 14.5%
Total Liabilities
$778.7M
↑ 3.3%
Shareholders' Equity
$5.3M
↓ 98.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 4/10/2026 | View on SEC |
| 4 | 4/3/2026 | View on SEC |
| 144 | 4/1/2026 | View on SEC |
| SCHEDULE 13G/A | 3/27/2026 | View on SEC |
| 8-K | 3/6/2026 | View on SEC |
| 4 | 3/5/2026 | View on SEC |
| 3 | 3/5/2026 | View on SEC |
| 8-K | 3/5/2026 | View on SEC |
| 4 | 3/4/2026 | View on SEC |
| 4 | 3/4/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PACB |
| Company Name | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. |
| CIK | 1299130 |
| Sector | Laboratory Analytical Instruments |
| Industry | Accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 3826 |
| SIC Description | Laboratory Analytical Instruments |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 650-521-8000 |